Claudio, Ancero R.
HRN: 01-01-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFTRIAXONE 1G (VIAL)
09/29/2022
10/05/2022
IVTT
2g
Q24
Elevated WBC With Perisitent LBM
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes